Arkolith/Insider Trading/NBIX/Form 4

Lippoldt Darin

Chief Legal OfficerNEUROCRINE BIOSCIENCES INC (NBIX) · full profile →Form 4 · filed Jun 30, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.7M
Net Open-Market Flow
-$1.7M
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 29, 2026Option exercise(M)2K$81.49$138K56K
Jun 29, 2026Sell(S)2K$170.81$289K55K
Jun 29, 2026Option exercise(M)8K$81.49$661K63K
Jun 29, 2026Sell(S)8K$170.03$1.4M55K
Jun 26, 2026Option exercise(M)200$81.49$16K55K
Jun 26, 2026Sell(S)200$169.56$34K55K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 29, 2026Option exercise(M)8K—$017K
Jun 29, 2026Option exercise(M)2K—$015K
Jun 26, 2026Option exercise(M)200—$025K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001504783-26-000015) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML